A nasal spray is safe and effective at rapidly treating cluster headaches, which are considered to be the most painful kind of headache with few treatment options, according to a study published in the Aug. 28, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
A team of scientists, including three researchers at George Mason University, found that the mineral zinc could play a role in the development of macular degeneration. In studying eye tissue samples, the researches found that deposits, that are hallmarks of age-related macular degeneration (AMD), contain large amounts of zinc.
University of Arkansas researchers have found a simple, inexpensive way to create a nanowire coating on the surface of biocompatible titanium that can be used to create more effective surfaces for hip replacement, dental reconstruction and vascular stenting.
People who stopped taking cholesterol-lowering drugs after being hospitalized for a stroke are at greater risk of death or dependency within three months of the stroke, according to a study published in the Aug. 28, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
A landmark study by University of Western Sydney researchers has found people over 50 who take calcium supplements suffer fewer fractures and enjoy a better quality of life.
University of Minnesota researchers have discovered that treating people who have early cardiovascular abnormalities, but show no symptoms of cardiovascular disease, can slow progression and even reverse damage to the heart and blood vessels.
Findings released today by the Health Department shed new light on the health effects of exposure to dust and debris among workers who responded to the World Trade Center disaster on September_11, 2001.
HSP 90 inhibitors, which are finding favor in fighting cancer, may also help battle overwhelming infection in intensive care patients, researchers say.
On 23 August 2007, Dr Howard Zucker, Head of the WHO cluster Health Technology and Pharmaceuticals and Representative of the Director-General on Intellectual Property, Innovation and Public Health of the World Health Organization (WHO), was visiting the Paul-Ehrlich-Institut (PEI) at Langen near Frankfurt am Main, Germany.
Avastin (bevacizumab), Roche’s innovative anti-cancer drug, was approved today in Europe for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), in combination with platinum-based chemotherapy.